Skip to main content

Published locations for Adjuvant Olaparib Improves Outcomes in High-Risk, HER2-Negative Early Breast Cancer Patients With Germline BRCA1 and BRCA2 Mutations

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Adjuvant Olaparib Improves Outcomes in High-Risk, HER2-Negative Early Breast Cancer Patients With Germline BRCA1 and BRCA2 Mutations

User login

  • Reset your password
  • /content/adjuvant-olaparib-improves-outcomes-high-risk-her2-negative-early-breast-cancer-patients
  • /jcomjournal/article/249044/oncology/adjuvant-olaparib-improves-outcomes-high-risk-her2-negative